| 000 | 01803 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515135404.0 | ||
| 264 | 0 | _c20100831 | |
| 008 | 201008s 0 0 chi d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZeng, Si-Yuan | |
| 245 | 0 | 0 |
_a[Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma]. _h[electronic resource] |
| 260 |
_bAi zheng = Aizheng = Chinese journal of cancer _cSep 2008 |
||
| 300 |
_a942-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; English Abstract; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aBrachytherapy _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCobalt Radioisotopes _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIridium Radioisotopes _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aRadioisotope Teletherapy _xadverse effects |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
| 700 | 1 | _aLi, Long-Yu | |
| 700 | 1 | _aShu, Kuan-Yong | |
| 700 | 1 | _aPan, Mei | |
| 700 | 1 | _aLi, Han-Ping | |
| 700 | 1 | _aLuo, Bing | |
| 773 | 0 |
_tAi zheng = Aizheng = Chinese journal of cancer _gvol. 27 _gno. 9 _gp. 942-6 |
|
| 999 |
_c18267039 _d18267039 |
||